A One Visit Follow Up of Adults With Fabry Disease Who Started Long-term Enzyme Replacement Therapy As Children

NAUnknownINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 10, 2018

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Quality of LifeRenal InsufficiencyCardiac Event
Interventions
OTHER

General and Neurological examination

Information about your general health, neurological symptoms and current medications with be collected

OTHER

Vital signs

Height, weight, blood pressure, heart rate, and respiratory rate and temperature will be measured.

PROCEDURE

12 lead electrocardiogram

A non-invasive test that measures the electrical activity of the heart

PROCEDURE

Echocardiogram

A non-invasive sonogram of the heart

PROCEDURE

Blood draw

Blood will be drawn to evaluate general health and renal function (kidney health)

PROCEDURE

Urine collection

Urine will be collection to evaluate renal function (kidney health)

PROCEDURE

2-hour Holter Monitor

A non-invasive test that measures the electrical activity of the heart continuously over 2 hours

OTHER

Brief Pain Inventory questionnaire

A questionnaire about daily pain

OTHER

Quality of Life questionnaire

A questionnaire about the impact of disease on their activities of daily living and quality of life

Trial Locations (1)

75246

Baylor University Medical Center, Dallas

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Shire

INDUSTRY

lead

Baylor Research Institute

OTHER